Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market Report 2026

Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market Overview

• Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis market size has reached to $2.01 billion in 2025 • Expected to grow to $4.81 billion in 2030 at a compound annual growth rate (CAGR) of 19% • Growth Driver: Rising Cardiovascular Disease Rates Driving Demand For Early Intervention Solutions • Market Trend: AI Marketplaces Transform Early Cardiac Diagnosis • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market?

Artificial intelligence electrocardiogram (ECG) analysis refers to the application of machine learning and deep learning algorithms to automatically interpret ECG signals. It enables rapid and accurate detection of cardiac abnormalities, enhances diagnostic precision, reduces human error, and supports timely clinical decision-making. The main components of artificial intelligence (AI) electrocardiogram (ECG) analysis are software, hardware, and services. Artificial intelligence electrocardiogram analysis software refers to advanced digital solutions that utilize artificial intelligence algorithms to automatically interpret electrocardiogram data, enabling accurate and efficient detection of cardiac abnormalities. It is available in two types, including on-premise and cloud-based. It is commonly used to detect and monitor medical conditions such as cardiac arrhythmias, heart failure, ischemic heart disease, and coronary artery disease, finding applications in hospitals, clinics, and others.

What Is The Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market Growth Forecast?

The artificial intelligence (ai) electrocardiogram (ecg) analysis market size is expected to see rapid growth in the next few years. It will grow to $4.81 billion in 2030 at a compound annual growth rate (CAGR) of 19.0%. The growth in the forecast period can be attributed to advancements in deep learning algorithms for ecg, increasing adoption of wearable and portable ecg devices, expansion of telehealth and remote monitoring, growing investment in cloud-based healthcare solutions, regulatory approvals for ai-assisted diagnostic tools. Major trends in the forecast period include increasing adoption of ai-driven ecg analysis in hospitals, integration of wearable ecg monitoring devices with ai platforms, rising demand for remote ecg monitoring and telecardiology services, focus on real-time cardiac data visualization and decision support, expansion of cloud-based ecg analysis solutions.

Global Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market Segmentation

1) By Component: Software, Hardware, Services 2) By Type: On-Premise, Cloud-Based 3) By Medical Condition: Cardiac Arrhythmias, Heart Failure, Ischemic Heart Disease And Coronary Artery Disease 4) By Application: Hospital, Clinic, Other Applications Subsegments: 1) By Software: Artificial Intelligence Electrocardiogram (ECG) Interpretation Platforms, Machine Learning-Based Electrocardiogram Diagnostic Tools, Deep Learning Electrocardiogram (ECG) Analysis Software, Cloud-Based Electrocardiogram Analysis Systems, Real-Time Electrocardiogram Data Visualization Software 2) By Hardware: Wearable Electrocardiogram Monitoring Devices, Portable Electrocardiogram Acquisition Units, Smart Electrocardiogram Patches, Multi-Lead Electrocardiogram Recording Machines, Sensor-Integrated Electrocardiogram Devices 3) By Services: Remote Electrocardiogram Monitoring Services, Electrocardiogram Data Annotation And Labeling Services, Artificial Intelligence Algorithm Training And Validation For Electrocardiogram, Technical Support And Software Integration For Electrocardiogram, Clinical Electrocardiogram Reporting And Interpretation Services

What Is The Driver Of The Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market?

The rising burden of cardiovascular diseases is expected to propel the growth of the AI powered electrocardiogram (ECG) analysis market going forward. Cardiovascular diseases refer to disorders affecting the heart and blood vessels, including coronary heart disease, heart failure, stroke, and hypertension. The increase in cardiovascular disease burden is due to factors such as aging populations, metabolic risks, poor diet, and sedentary lifestyles, which collectively elevate the risk of heart-related complications. AI powered ECG analysis supports healthcare by enabling early detection of cardiac abnormalities, streamlining diagnostic workflows, and improving clinical decision-making to enhance patient outcomes. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2023, cardiovascular disease claimed 919,032 lives, accounting for one in every three deaths. Coronary heart disease remained the most prevalent form of heart disease, and notably, about one in six deaths from cardiovascular diseases occurred among adults younger than 65 years. Therefore, the rising prevalence of cardiovascular diseases is driving the adoption of AI powered ECG analysis.

Key Players In The Global Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market

Major companies operating in the artificial intelligence (ai) electrocardiogram (ecg) analysis market are iRhythm Technologies Inc., Viz.ai Inc., Tempus Labs Inc., HeartSciences Inc., Neurosoft Software Production S.A., Tricog Health Services Pvt. Ltd., Anumana Inc., IDOVEN S.L., Ultromics Limited., VUNO Inc., Cardio.AI Inc., Powerful Medical s.r.o., RSIP Vision Ltd., AccurKardia Inc., Cardiologs Technologies SAS, Cardiomatics Sp. z o.o., Cordys Analytics B.V., PulseAI Ltd., Vektor Medical Inc., DeepECG Inc

Global Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market Trends and Insights

Major companies operating in the artificial intelligence (AI) electrocardiogram (ECG) analysis market are focusing on developing technologically advanced solutions, such as artificial intelligence marketplaces, to streamline early cardiac diagnosis and enhance clinical workflows. Artificial intelligence marketplaces are centralized platforms that offer access to multiple validated AI diagnostic tools, enabling healthcare providers to integrate advanced algorithms into clinical workflows for faster and more accurate diagnoses. For instance, in July 2025, Koninklijke Philips N.V., a Netherlands-based health technology company, launched Philips' electrocardiogram artificial intelligence marketplace, an advanced platform designed to integrate artificial intelligence-powered diagnostic tools directly into its IntelliSpace ECG and cardiograph systems. The marketplace initially features FDA-cleared algorithms, beginning with Anumana’s electrocardiogram artificial intelligence low ejection fraction algorithm, and delivers these tools at the point of care. This innovation accelerates ECG review, enables earlier detection of heart failure through analysis of standard 12-lead resting ECGs, and enhances both clinical efficiency and diagnostic accuracy.

What Are Latest Mergers And Acquisitions In The Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market?

In June 2024, AI/ML Innovations Inc., a Canada-based company focused on artificial intelligence and machine learning technologies for healthcare, acquired proprietary neural network technology from Naiad Lab Inc. for an undisclosed amount. Through this acquisition, AI/ML Innovations aims to enhance its cardiovascular analytics portfolio by integrating Naiad Lab’s Long ECG Neural Net, capable of detailed beat-by-beat ECG labeling over extended recordings, and the Neural Network Store (NNStore), a subscription-based platform for AI-enabled ECG analysis. Naiad Lab Inc. is a Canada-based company that specializes in neural-network architectures for ECG signal interpretation and cardiovascular insights.

Regional Outlook

North America was the largest region in the artificial intelligence (AI) electrocardiogram (ECG) analysis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Artificial Intelligence (AI) Electrocardiogram (ECG) Analysis Market?

The artificial intelligence (AI) electrocardiogram (ECG) analysis market consists of revenues earned by entities by providing services such as algorithm customization, real-time electrocardiogram data interpretation, artificial intelligence (AI)-based risk stratification, automated electrocardiogram reporting, and predictive cardiac event alerts. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence electrocardiogram analysis market also includes sales of machine learning engines, artificial intelligence-integrated diagnostic dashboards, electrocardiogram signal processing modules, wearable-compatible analysis chips, and mobile electrocardiogram data viewers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.